Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrataGraft in pediatric DPT burns
NCT05517902Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Apr 2023
- Primary completion
- May 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen in deep partial thickness burn (DPT), sponsored by Mallinckrodt Pharmaceuticals. Started Apr 2023; status: completed.
02
Drugs
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen
03
Conditions
deep partial thickness burn (DPT)
Beyond the preview
Go deeper on NCT05517902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517902.